FAST-Affiliated Research Program at UCLA is awarded $5.8M to advance gene therapy for Angelman syndrome.
UCLA’s Dr. Roger Hollis received a $5.8 million CIRM award to advance a stem cell gene therapy for Angelman syndrome, moving the FAST-backed program closer to a Phase 1 trial.